NDC 0078-0393 – Simulect
Basiliximab 10 mg/2.5mL · Injection, Powder, For Solution · Intravenous
Product NDC0078-0393
Product details
- Brand name
- Simulect
- Generic name
- Basiliximab
- Labeler
- Novartis Pharmaceuticals Corporation
- Dosage form
- Injection, Powder, For Solution
- Route
- Intravenous
- Marketing category
- BLA · BLA103764
- Marketed since
- May 12, 1998
- Listing expires
- December 31, 2026
- Pharmacologic class
- Interleukin-2 Receptor Blocking Antibody
Active ingredients
- Basiliximab 10 mg/2.5mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0078-0393-61 | 1 VIAL, SINGLE-USE in 1 CARTON (0078-0393-61) / 2.5 mL in 1 VIAL, SINGLE-USE | May 12, 1998 |
Other Simulect products
- 0078-0331 Basiliximab 20 mg/5mL · Injection, Powder, For Solution · Novartis Pharmaceuticals Corporation